Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Carlsmed, Inc. (CARL : NSDQ)

• Company Description    Carlsmed Inc. is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions. Carlsmed Inc. is based in CARLSBAD, Calif. Number of Employees: 127

• Price / Volume Information    Yesterday's Closing Price: $14.57 Daily Weekly Monthly 20 Day Moving Average: 132,665 shares Shares Outstanding: 26.73 (millions) Market Capitalization: $389.48 (millions) Beta: 52 Week High: $17.19 52 Week Low: $10.65 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 17.31% 18.34% 12 Week 9.88% 9.74% Year To Date 17.98% 17.40%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1800 ASTON AVENUE SUITE 100 - CARLSBAD,CA 92008 USA ph: 858-295-9290 fax: - None http://www.carlsmed.com

• General Corporate Information    Officers Michael Cordonnier - Chief Executive Officer Leonard Greenstein - Chief Financial Officer Kevin O`Boyle - Director Niall Casey - Director Jonathan Root - Director Peer Information Carlsmed, Inc. (HLIS) Carlsmed, Inc. (AZTA) Carlsmed, Inc. (APYI) Carlsmed, Inc. (RNVA) Carlsmed, Inc. (HMSY) Carlsmed, Inc. (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 14280C105 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 12/01/25 Next Expected EPS Date: 07/21/26 Share - Related Items Shares Outstanding: 26.73 Most Recent Split Date: (:1) Beta: Market Capitalization: $389.48 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.43 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.65 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 17.77% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 07/21/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.92 Price/Cash Flow: - Price / Sales: 7.71 EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: 20.00% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: 15.99% ROE 12/31/25 - -72.60 09/30/25 - - 06/30/25 - - ROA 12/31/25 - -27.93 09/30/25 - - 06/30/25 - - Current Ratio 12/31/25 - 8.87 09/30/25 - 12.03 06/30/25 - 4.87 Quick Ratio 12/31/25 - 8.74 09/30/25 - 11.91 06/30/25 - 4.76 Operating Margin 12/31/25 - -58.67 09/30/25 - - 06/30/25 - - Net Margin 12/31/25 - -58.67 09/30/25 - - 06/30/25 - - Pre-Tax Margin 12/31/25 - -58.67 09/30/25 - - 06/30/25 - - Book Value 12/31/25 - 3.72 09/30/25 - 4.01 06/30/25 - -3.13 Inventory Turnover 12/31/25 - 8.80 09/30/25 - - 06/30/25 - - Debt-to-Equity 12/31/25 - 0.16 09/30/25 - 0.14 06/30/25 - - Debt-to-Capital 12/31/25 - 13.44 09/30/25 - 12.65 06/30/25 - 37.56

Powered by Zacks Investment Research ©